Search PDMR transactions

Notifier
Name
Keith Alexander
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Keith Alexander
Position
Chief Financial Officer
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
ExpreS2ion Biotech Holding AB
LEI
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subscription right/Unit right EXPRES2 UR SE0014957957 Acquisition 4,998 Quantity 0.173 SEK 15/10/2020 NASDAQ STOCKHOLM AB
Subscription right/Unit right EXPRES2 UR SE0014957957 Acquisition 1,410 Quantity 0.13 SEK 15/10/2020 NASDAQ STOCKHOLM AB
Share EXPRES2 SE0008348262 Acquisition 4,272 Quantity 12.00 SEK 19/10/2020 NASDAQ STOCKHOLM AB
Aggregation
Name ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
EXPRES2 UR SE0014957957 Acquisition 15/10/2020 NASDAQ STOCKHOLM AB 6,408 (Quantity) 0.16353839 SEK
EXPRES2 SE0008348262 Acquisition 19/10/2020 NASDAQ STOCKHOLM AB 4,272 (Quantity) 12.00 SEK
<< Back